Drug Profile

Alzheimer's disease peptide vaccine - POP Biotechnologies/EuPOP life sciences

Alternative Names: Padivax™

Latest Information Update: 13 Oct 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator EUPOP Life Sciences
Class Alzheimer vaccines; Peptide vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Alzheimer's disease

Most Recent Events

13 Sep 2024 Preclinical trials in Alzheimer's disease in USA (IM)
13 Sep 2024 Pharmacodynamics and adverse event data from a preclinical study in Alzheimer's disease released by POP Biotechnology
13 Sep 2024 EuPOP Life Sciences plans a clinical trials for Alzheimer's disease

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com